These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 76489)

  • 1. Platelet support in polysensitized patients: role of HLA specificities and crossmatch testing for donor selection.
    Gmür J; von Felten A; Frick P
    Blood; 1978 May; 51(5):903-9. PubMed ID: 76489
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cross-reactivity of HLA antigens of the donor and patient--a cause of unsuccessful thrombocyte transfusion in patients with HLA antibodies].
    Májský A
    Bratisl Lek Listy; 1989 Apr; 90(4):286-9. PubMed ID: 2765960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates.
    Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG
    Transfusion; 1977; 17(6):657-61. PubMed ID: 595123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 6. Four crossmatch methods to select platelet donors.
    Kakaiya RM; Gudino MD; Miller WV; Sherman LA; Katz AJ; Wakem CJ; Krugman DJ; Klatsky AU; Kiraly TR
    Transfusion; 1984; 24(1):35-41. PubMed ID: 6364475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
    Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
    Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
    Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
    Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
    Wu KK; Hoak JC; Koepke JA; Thompson JS
    Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins.
    Thompson JS; Severson CD; Parmely MJ; Marmorstein BL; Simmons A
    N Engl J Med; 1971 May; 284(20):1120-5. PubMed ID: 5553486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological principles of transfusion of blood platelet and granulocyte concentrates].
    Zupańska B
    Acta Haematol Pol; 1979 Oct; 10(4):327-32. PubMed ID: 539356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Imporatance of the system of antigens of polymorphonuclear leukocytes in the sensitization of recipients in blood transfusion].
    Zotikov EA; Poreshina LP; Kut'ina RM; Manishkina RP; Musatova VS
    Probl Gematol Pereliv Krovi; 1975 Jul; 20(7):3-6. PubMed ID: 1197229
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic specificities detected on papainized human granulocytes by microgranulocytotoxicity.
    Drew SI; Bergh O; McClelland J; Mickey R; Terasaki PI
    Transplant Proc; 1977 Mar; 9(1):639-45. PubMed ID: 68596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of four methods for platelet compatibility testing.
    McFarland JG; Aster RH
    Blood; 1987 May; 69(5):1425-30. PubMed ID: 3552075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.